NCT01264744View on ClinicalTrials.gov

Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test)

CompletedOBSERVATIONAL
Enrollment

174

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Bladder Cancers
Trial Locations (3)

76508

Sheila Dobin, Ph.D., Temple

90073

VA Hospital, Los Angeles

07083

PLUS Diagnostics, Union

Sponsors
All Listed Sponsors
lead

Applied Spectral Imaging Ltd.

INDUSTRY

NCT01264744 - Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test) | Biotech Hunter | Biotech Hunter